Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-12 08:27 am Purchase | 13D | CASI PHARMACEUTICALS HLDGS INC CASI | He Wei-Wu | 3,257,891 20.940% | 420,000 (+14.80%) | View |
| 2023-04-18 4:00 pm Purchase | 13D | CASI PHARMACEUTICALS HLDGS INC CASI | He Wei-Wu | 2,837,891 19.750% | 2,837,891 (New Position) | View |
| 2022-06-21 4:26 pm Purchase | 13D | CASI PHARMACEUTICALS HLDGS INC CASI | He Wei-Wu | 2,761,349 18.950% | 2,761,349 (New Position) | View |
| 2021-11-23 5:15 pm Purchase | 13D | CASI PHARMACEUTICALS HLDGS INC CASI | He Wei-Wu | 25,981,994 17.470% | 4,380,000 (+20.28%) | View |
| 2021-02-03 4:01 pm Purchase | 13D | CASI PHARMACEUTICALS HLDGS INC CASI | He Wei-Wu | 21,601,994 16.260% | 3,847,471 (+21.67%) | View |
| 2020-07-29 5:16 pm Purchase | 13D | CASI PHARMACEUTICALS HLDGS INC CASI | He Wei-Wu | 17,754,523 13.780% | 5,208,996 (+41.52%) | View |
| 2020-03-24 4:01 pm Purchase | 13D | CASI PHARMACEUTICALS HLDGS INC CASI | He Wei-Wu | 12,545,527 12.070% | 3,239,569 (+34.81%) | View |